Cooper Companies | Bienes



Assets Cambio Fecha
Abbott USD 81.45B 34M 2025-03
Align Technology USD 6.1B 111.78M 2025-03
AtriCure USD 591.63M 17.7M 2025-03
Avanos Medical USD 1.15B 502M 2024-12
Bausch Health Companies USD 26.42B 102M 2025-03
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Dentsply International USD 5.75B 873M 2024-12
Dexcom USD 6.75B 267.2M 2025-03
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.55B 183.6M 2025-03
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 19.22B 477.2M 2025-03
J&J USD 193.67B 13.57B 2025-03
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.47B 49.37M 2025-03
Novartis USD 102.25B 1.28B 2024-12
ResMed USD 7.57B 425.49M 2025-03
STAAR Surgical USD 509.52M 28.07M 2024-12
Steris USD 10.01B 233.78M 2024-12
Stryker USD 46.01B 3.04B 2025-03
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teleflex USD 7.16B 65.38M 2025-03
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Cooper Companies Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.